The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2006
DOI: 10.1016/j.drudis.2006.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Critical review of the role of HTS in drug discovery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
155
0
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 224 publications
(156 citation statements)
references
References 17 publications
0
155
0
1
Order By: Relevance
“…20,21 The analysis of data generated in HTS has continuously evolved as the compound collections grew in size and chemical diversity; from the original simple activity-driven hit selection, HTS scientists today use more sophisticated methods and algorithms to enrich the chemical diversity of the output. There is, however, still room to better exploit the information that the HTS generates, in particular with the use of the single-shot data produced during the primary-screening campaigns.…”
Section: Discussionmentioning
confidence: 99%
“…20,21 The analysis of data generated in HTS has continuously evolved as the compound collections grew in size and chemical diversity; from the original simple activity-driven hit selection, HTS scientists today use more sophisticated methods and algorithms to enrich the chemical diversity of the output. There is, however, still room to better exploit the information that the HTS generates, in particular with the use of the single-shot data produced during the primary-screening campaigns.…”
Section: Discussionmentioning
confidence: 99%
“…The solubility of recently discovered APIs is often very poor (Macarron, 2006;Vasconcelos et al, 2007) in the gastrointestinal fluids, resulting in low oral bioavailability (Wong et al, 2006). Methods that are available to eliminate the solubility problem (Fahr and Liu, 2007;Sarode et al, 2014) are either costly or their industrial applicability is limited .…”
Section: Introductionmentioning
confidence: 99%
“…Thus, the dissolution rate is required to achieve high bioavaibility of IBU. The dissolution rate could be improved by decreasing the particle size, leads to higher surface area of reaction [3][4][5][6][7]. It is very common that pharmaceutical technology uses the micronization process to reduce the particle size in order to increase the dissolution rate of drugs [8][9].…”
Section: Introductionmentioning
confidence: 99%